STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.
Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories. In addition to hardware and consumables, STERIS provides validation, advisory and technical field services such as installation, maintenance, validation testing and training to help customers meet regulatory and operational requirements.
STERIS serves a worldwide customer base that includes hospitals and health systems, ambulatory surgery centers, pharmaceutical and biotechnology manufacturers, medical device companies, and research institutions. The company operates manufacturing, distribution and service facilities across multiple regions to support customers’ clinical and production needs and to provide local service and regulatory support.
Over time STERIS has expanded its product and service scope to address a range of infection-prevention and contamination-control challenges across clinical and industrial settings. The company positions itself as a partner to organizations seeking to improve patient safety, ensure regulatory compliance and maintain uptime for critical sterilization and reprocessing operations.